News & Updates
Filter by Specialty:
Aspirin may improve survival in PIK3CA-mutated colon cancer
Adjuvant treatment with aspirin appears to provide some protection in patients with resected, PIK3CA-mutant stage II and III colon cancer, demonstrating a clinically significant improvement (43 percent) in disease-free survival (DFS), suggests a study presented at ESMO Congress 2024.
Aspirin may improve survival in PIK3CA-mutated colon cancer
06 Oct 2024
IBD patients at high myocarditis risk for up to 20 years
The risk of myocarditis appears to be elevated among patients with inflammatory bowel disease (IBD) for ≥20 years following diagnosis, suggests a study in Sweden. However, absolute risks remain low.
IBD patients at high myocarditis risk for up to 20 years
21 Sep 2024
Study warns of increased PD risk among people with upper GI mucosal damage history
A history of upper gastrointestinal (GI) mucosal damage, such as peptic ulcer disease and erosions, has been associated with subsequent incidence of Parkinson’s disease (PD) in a study.
Study warns of increased PD risk among people with upper GI mucosal damage history
17 Sep 2024
COVID-19 variants carry no increased autoimmune sequelae risk
COVID-19 variants delta and omicron BA.1 or BA.2 do not pose a substantial threat of long-term autoimmune complications, except for a modest elevation in inflammatory bowel disease and bullous skin disorders among hospitalized patients during the omicron predominance in Singapore, as shown in a study.